Get started
RocketTickers

ALLO Announces FDA Clearance of the IND for ALLO-501

Long
Allogene Therapeutics, Inc. (NASDAQ:ALLO)  
RocketTickers  
NASDAQ:ALLO   Allogene Therapeutics, Inc.
Beyond Technical Analysis
0
1
beyondta
ALLO: Allogene Therapeutics, Inc.
2019-01-28 08:30:00
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.